Home › Non-Small Cell Lung Cancer › Georgia › Savannah
Non-Small Cell Lung Cancer clinical trials in Savannah, GA
10 studies for Non-Small Cell Lung Cancer are looking for participants at sites in and around Savannah (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RecruitingPhase 3
- Lewis Cancer and Research Pavilion at Saint Joseph's/Candler, Savannah
- Saint Joseph's/Candler - Bluffton Campus, Bluffton · 18 mi away
- South Carolina Cancer Specialists PC, Hilton Head Island · 22 mi away
A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)
RecruitingPhase 3
- Low Country Cancer Care ( Site 0156), Savannah
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
RecruitingPhase 3
- Lewis Cancer and Research Pavilion ( Site 0063), Savannah
- Saint Joseph's Candler Health System ( Site 4010), Bluffton · 18 mi away
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
RecruitingPhase 3
- Research Site, Savannah
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
RecruitingPhase 3
- Summit Cancer Care PC, Savannah
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RecruitingPhase 2
- Lewis Cancer and Research Pavilion at Saint Joseph's/Candler, Savannah
- Saint Joseph's/Candler - Bluffton Campus, Bluffton · 18 mi away
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
RecruitingPhase 2/3
- Lewis Cancer and Research Pavilion at Saint Joseph's/Candler, Savannah
- Saint Joseph's/Candler - Bluffton Campus, Bluffton · 18 mi away
- South Carolina Cancer Specialists PC, Hilton Head Island · 22 mi away
JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer
RecruitingPhase 3
- Curtis and Elizabeth Anderson Cancer, Savannah
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RecruitingObservational study
- Lewis Cancer and Research Pavilion at Saint Joseph's/Candler, Savannah
- Saint Joseph's/Candler - Bluffton Campus, Bluffton · 18 mi away
- The Radiation Oncology Center-Hilton Head/Bluffton, Hilton Head Island · 22 mi away
- and 1 more
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Savannah
Non-Small Cell Lung Cancer trials in other cities
- Houston, TX145 studies
- New York City, NY121 studies
- Arlington, VA104 studies
- Nashville, TN97 studies
- Boston, MA90 studies
- Los Angeles, CA87 studies
- St. Louis, MO73 studies
- Chicago, IL61 studies
- Baltimore, MD60 studies
- San Antonio, TX59 studies
- Columbus, OH57 studies
- Washington, DC55 studies
Other studies in Savannah
- Breast Cancer11 studies
- Lung Cancer10 studies
- Cancer (all types)6 studies
- Major Depressive Disorder6 studies
- Type 2 Diabetes6 studies
- Melanoma5 studies
- COPD5 studies
- Ovarian Cancer4 studies
- Colorectal Cancer4 studies
- Non-Hodgkin Lymphoma3 studies
- Mania3 studies
- Acute Myeloid Leukemia3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.